Arrowstreet Capital, Limited Partnership Bausch Health Companies Inc. Transaction History

Arrowstreet Capital, Limited Partnership

$114 Billion
Q2 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 4,238,365 shares of BHC stock, worth $35 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,238,365

Previous 4,161,129 1.86%

Holding current value

$35 Million

Previous $44.1 Million 33.0%

% of portfolio

0.03%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.1 - $10.41 $471,139 - $804,026	77,236 Added 1.86%	4,238,365 $29.6 Million
Q1 2024 May 15, 2024	BUY	$7.77 - $10.61 $27.1 Million - $37 Million	3,483,897 Added 514.43%	4,161,129 $44.1 Million
Q4 2023 Feb 14, 2024	SELL	$6.53 - $8.23 $4.59 Million - $5.79 Million	-703,490 Reduced 50.95%	677,232 $5.43 Million
Q3 2023 Nov 14, 2023	BUY	$7.69 - $9.71 $10.6 Million - $13.4 Million	1,380,722 New	1,380,722 $11.4 Million
Q4 2022 Feb 14, 2023	SELL	$6.09 - $7.93 $2.79 Million - $3.64 Million	-458,564 Reduced 38.63%	728,350 $4.57 Million
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $15.5 Million - $31.3 Million	-3,394,663 Reduced 74.09%	1,186,914 $8.19 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $23.63 $28.5 Million - $95.5 Million	4,041,062 Added 747.63%	4,581,577 $38.3 Million
Q1 2022 May 13, 2022	BUY	$21.6 - $27.79 $8.96 Million - $11.5 Million	414,858 Added 330.15%	540,515 $12.3 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $2.89 Million - $3.65 Million	125,657 New	125,657 $3.47 Million
Q1 2021 May 14, 2021	SELL	$21.37 - $34.38 $286,358 - $460,692	-13,400 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$15.31 - $21.12 $1.28 Million - $1.76 Million	-83,400 Reduced 86.16%	13,400 $278,000
Q3 2020 Nov 12, 2020	BUY	$14.88 - $20.13 $1.44 Million - $1.95 Million	96,800 New	96,800 $1.5 Million
Q2 2020 Aug 12, 2020	SELL	$13.31 - $20.51 $12.8 Million - $19.7 Million	-961,559 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$12.98 - $30.25 $11 Million - $25.7 Million	851,159 Added 770.98%	961,559 $14.9 Million
Q4 2019 Feb 13, 2020	SELL	$18.89 - $31.89 $3.36 Million - $5.67 Million	-177,900 Reduced 61.71%	110,400 $3.31 Million
Q3 2019 Nov 14, 2019	SELL	$20.88 - $25.66 $8.15 Million - $10 Million	-390,301 Reduced 57.52%	288,300 $6.3 Million
Q2 2019 Aug 14, 2019	BUY	$20.52 - $26.45 $13.7 Million - $17.6 Million	667,001 Added 5750.01%	678,601 $17.1 Million
Q1 2019 May 15, 2019	SELL	$20.23 - $26.29 $17.9 Million - $23.3 Million	-885,254 Reduced 98.71%	11,600 $287,000
Q4 2018 Feb 14, 2019	SELL	$17.64 - $28.32 $25.3 Million - $40.5 Million	-1,431,756 Reduced 61.49%	896,854 $16.6 Million
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $48.1 Million - $59.8 Million	2,328,610 New	2,328,610 $59.8 Million

Others Institutions Holding BHC

# of Institutions

275

Shares Held

279M

Call Options Held

5.68M

Put Options Held

17.4M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.99B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership Bausch Health Companies Inc. Transaction History